Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 38693

1.

EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.

Takada H, Imadome KI, Shibayama H, Yoshimori M, Wang L, Saitoh Y, Uota S, Yamaoka S, Koyama T, Shimizu N, Yamamoto K, Fujiwara S, Miura O, Arai A.

PLoS One. 2017 Mar 27;12(3):e0174136. doi: 10.1371/journal.pone.0174136. eCollection 2017 Mar 27.

2.

Germline variation in the 3'-untranslated region of the POU2AF1 gene is associated with susceptibility to lymphoma.

Zhai K, Chang J, Hu J, Wu C, Lin D.

Mol Carcinog. 2017 Mar 27. doi: 10.1002/mc.22652. [Epub ahead of print]

PMID:
28345816
3.

2B4-SAP signaling is required for the priming of naive CD8<sup>+</sup> T cells by antigen-expressing B cells and B lymphoma cells.

Huang YH, Tsai K, Tan SY, Kang S, Ford ML, Harder KW, Priatel JJ.

Oncoimmunology. 2016 Dec 27;6(2):e1267094. doi: 10.1080/2162402X.2016.1267094. eCollection 2016 Dec 27.

PMID:
28344876
4.

Lymphoma development and survival in refractory coeliac disease type II: Histological response as prognostic factor.

Nijeboer P, van Wanrooij R, van Gils T, Wierdsma NJ, Tack GJ, Witte BI, Bontkes HJ, Visser O, Mulder C, Bouma G.

United European Gastroenterol J. 2017 Mar;5(2):208-217. doi: 10.1177/2050640616646529. Epub 2016 Jun 23.

PMID:
28344788
5.

Surgical Excision of Mycosis Fungoides Using Thumb-Sparing Reconstruction.

McEvenue G, Kim A, Binhammer P.

Hand (N Y). 2017 Mar;12(2):NP22-NP26. doi: 10.1177/1558944716669085. Epub 2016 Sep 23.

PMID:
28344538
6.

Primary Cutaneous Anaplastic Large Cell Lymphoma.

Brown RA, Fernandez-Pol S, Kim J.

J Cutan Pathol. 2017 Mar 25. doi: 10.1111/cup.12937. [Epub ahead of print] Review.

PMID:
28342276
7.

Clinicopathological analysis of primary central nervous system NK/T-cell lymphoma: rare and localised aggressive tumour among extranasal NK/T-cell tumours.

Miyata-Takata T, Takata K, Kato S, Hu LM, Noujima-Harada M, Chuang SS, Sato Y, Maeda Y, Yoshino T.

Histopathology. 2017 Mar 25. doi: 10.1111/his.13223. [Epub ahead of print]

PMID:
28342197
8.

Development of a modified prognostic index of patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: a possible risk-adapted management strategies including allogeneic transplantation.

Fuji S, Yamaguchi T, Inoue Y, Utsunomiya A, Moriuchi Y, Uchimaru K, Owatari S, Miyagi T, Taguchi J, Choi I, Otsuka E, Nakachi S, Yamamoto H, Kurosawa S, Tobinai K, Fukuda T.

Haematologica. 2017 Mar 24. pii: haematol.2017.164996. doi: 10.3324/haematol.2017.164996. [Epub ahead of print]

9.

Epstein barr virus hemophagocytic lymphohistiocytosis related to rituximab use and immunopathogenetic insights.

Papageorgiou SG, Tsiodras S, Siakallis G, Bazani E, Spathis A, Poulakou G, Korkolopoulou P, Panayiotides I, Pappa V.

Pathol Res Pract. 2016 Dec;212(12):1194-1198. doi: 10.1016/j.prp.2016.10.003. Epub 2016 Oct 17.

PMID:
28340951
10.

Peripheral T-Cell Lymphoma: The Beginning of the End of the Beginning.

Jacobsen ED.

Hematol Oncol Clin North Am. 2017 Apr;31(2):xiii-xiv. doi: 10.1016/j.hoc.2017.01.001. No abstract available.

PMID:
28340884
11.

Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma.

Marchi E, Raufi AG, O'Connor OA.

Hematol Oncol Clin North Am. 2017 Apr;31(2):359-375. doi: 10.1016/j.hoc.2016.11.002. Review.

PMID:
28340883
12.

Autologous and Allogeneic Hematopoietic Cell Transplantation in Peripheral T/NK-cell Lymphomas: A Histology-Specific Review.

Dhawale TM, Shustov AR.

Hematol Oncol Clin North Am. 2017 Apr;31(2):335-357. doi: 10.1016/j.hoc.2016.11.003. Review.

PMID:
28340882
13.

Mycosis Fungoides and Sezary Syndrome.

Foss FM, Girardi M.

Hematol Oncol Clin North Am. 2017 Apr;31(2):297-315. doi: 10.1016/j.hoc.2016.11.008. Review.

PMID:
28340880
14.

Uncommon Variants of T-Cell Lymphomas.

Mehta-Shah N, Horwitz S.

Hematol Oncol Clin North Am. 2017 Apr;31(2):285-295. doi: 10.1016/j.hoc.2016.11.004. Review.

PMID:
28340879
15.

Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home.

Dittus C, Sloan JM.

Hematol Oncol Clin North Am. 2017 Apr;31(2):255-272. doi: 10.1016/j.hoc.2016.11.005. Review.

PMID:
28340877
16.

Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.

Makita S, Tobinai K.

Hematol Oncol Clin North Am. 2017 Apr;31(2):239-253. doi: 10.1016/j.hoc.2016.11.007. Epub 2017 Jan 30. Review.

PMID:
28340876
17.

Angioimmunoblastic T-Cell Lymphoma.

Broccoli A, Zinzani PL.

Hematol Oncol Clin North Am. 2017 Apr;31(2):223-238. doi: 10.1016/j.hoc.2016.12.001. Review.

PMID:
28340875
18.

Management of Anaplastic Large Cell Lymphoma.

Chihara D, Fanale MA.

Hematol Oncol Clin North Am. 2017 Apr;31(2):209-222. doi: 10.1016/j.hoc.2016.11.001. Review.

PMID:
28340874
19.

Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Review of Current Disease Understanding and Therapeutic Approaches.

Al-Zahrani M, Savage KJ.

Hematol Oncol Clin North Am. 2017 Apr;31(2):189-207. doi: 10.1016/j.hoc.2016.11.009. Review.

PMID:
28340873
20.

Extracorporeal photopheresis for the treatment of early-stage mycosis fungoides.

Lewis DJ, Duvic M.

Dermatol Ther. 2017 Mar 24. doi: 10.1111/dth.12485. [Epub ahead of print]

PMID:
28338261

Supplemental Content

Loading ...
Support Center